-
Diagnostics World News | When implementing a point-of-care testing (POCT) program in an organization with thousands of users across multiple sites, it helps to have a multidisciplinary committee to provide needed oversight, match the scope of testing to clinical need, and keep the lines of communication open. The hospital IT department is an “often overlooked” friend in the process.
Aug 26, 2021
-
Diagnostics World News | Connected diagnostics and care automation could remove one trillion dollars in annual global healthcare spending, or roughly 10% of the outlay in 2022, according to Ken Mayer, founder and CEO of Safe Health Systems, who presented yesterday at the Next Generation Dx Summit. The enabler may well be a digital health and diagnostic platform the company operates in partnership with the Mayo Clinic.
Aug 25, 2021
-
Diagnostics World News | Thanks to photoacoustics, a blend of modern-day ultrasound machines and lasers, physicians in the next decade could be using a routine imaging test to “hear” the sound signal of a future heart attack. As envisioned, photoacoustic imaging would likely serve as a complement to intravascular ultrasound (IVUS) or standard ultrasound by reporting on the whereabouts and inflammatory status of atherosclerotic plaque.
Aug 24, 2021
-
Diagnostics World News | For the benefit of laboratory and healthcare professionals, the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) published joint guidelines in 2015 aimed at standardizing terminology and the classification of sequence variants uncovered through genetic testing. Understandably, in the several years since then, there have been tremendous advances in this field of molecular diagnostics such as next-generation sequencing (NGS) technologies unlocking new opportunities to understand an individual’s unique genetic makeup. Armed with these insights, healthcare providers can personalize therapeutic options for their patients with genetic diseases, helping to manage or treat them altogether.
Aug 20, 2021
-
Diagnostic World News | Researchers at Massachusetts Institute of Technology have developed a urine-based molecular assay that can both reveal the presence of cancerous proteins and pinpoint a tumor’s location. The double-duty diagnostic nanosensor could one day be of clinical value in evaluating treatment response and long-term monitoring of tumor recurrence.
Aug 17, 2021